Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: everolimus|DRUG: abraxane
Sponsor: Rutgers, The State University of New Jersey
Collaborators: National Cancer Institute (NCI)